Biography:
Dr. Nejadnik graduated from the University of Louvain in Belgium for both his undergraduate degree in premedical studies, graduating Summa Cum Laude, and his medical degree (MD), graduating Magna Cum Laude. He completed post-graduate fellowships at Cornell University and Johns Hopkins University. Dr. Nejadnik was a member of the teaching faculty at University of California and Stanford University, and has held key roles Johnson & Johnson, Jazz Pharmaceuticals, Galena Biopharma, and Eureka Therapeutics. Dr. Nejadnik is currently Chief Medical Officer and Head of Research at SanBio, Inc.
Title : Efficacy and safety outcomes in patients with chronic traumatic brain injury: Final analysis of the randomized, double-blind, surgical sham-controlled phase 2 stemtra trial